Showing results (41-50 of 250) with videos related to
Sort By:
Pageof 25
Current Opinion in Cardiology|April 2, 2021
Triglycerides and cardiovascular diseaseOluwayemisi Esan, Anthony S WierzbickiExpert Opinion on Pharmacotherapy|October 17, 2014
Fibrates and niacin: is there a place for them in clinical practice?Anthony S Wierzbicki, Adie ViljoenInternational Journal of Clinical Practice|March 31, 2015
Improving the odds: ezetimibe and cardiovascular diseaseA Viljoen, A S WierzbickiClinical Medicine (London, England)|August 3, 2016
Drugs for hypercholesterolaemia - from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibitionAnthony S Wierzbicki, Paul GrantCurrent Drug Targets|April 10, 2009
Potential options to treat hypertriglyceridaemiaAdie Viljoen, Anthony S WierzbickiDrug Design, Development and Therapy|August 6, 2020
Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in TherapyOluwayemisi Esan, Anthony S WierzbickiCurrent Medical Research and Opinion|July 14, 2000
HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatinD P Mikhailidis, A S WierzbickiClinical Medicine (London, England)|January 17, 2020
Cardiovascular prevention: Frontiers in lipid guidelinesEun Ji Kim, Anthony S WierzbickiJournal of Cardiovascular Pharmacology and Therapeutics|July 2, 2013
Lipid-lowering agentsMfon Ewang-Emukowhate, Anthony S WierzbickiInternational Journal of Clinical Practice|November 26, 2018
Demand management of weekend haematology and clinical biochemistry requestsTim M Reynolds, Anthony S WierzbickiPageof 25